Just caught something wild with Lemonade stock this morning. Thing opened up nearly 14% at the bell, then absolutely tanked over the next hour and a half. By midday it was down 5.5%. Classic earnings whiplash.

So here's what went down: Q4 numbers were genuinely solid. Revenue jumped 53% year-over-year to $228 million, which beat analyst expectations. Gross profit surged 73%, and they actually cut their net loss per share from 42 cents to 29 cents. Free cash flow came in at $37 million too. On paper, this is the kind of report that should pump a stock.

But here's the catch—and why the market got cold feet. Lemonade was already trading at 8.9x sales going into earnings. That's absolutely wild for an insurance company. The next-most-expensive competitor in the space sits at 4.7x, and the sector average is like 1.4x. Wall Street had basically priced in perfection before the report even dropped. When management guided higher for next quarter and talked about breaking even by 2027, investors just... didn't buy it. The new Tesla insurance product they launched looks promising but it's too early to matter. Sometimes a company can nail earnings and still disappoint because the bar was set impossibly high.